يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Bittoni, A"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer

    المؤلفون: Haojie Li, Ashwini Arunachalam, Gregory M. Lubiniecki, Ramon E. Camacho, Marisa A. Bittoni, David P. Carbone, Xiting Cao, Yichen Zhong

    المصدر: Clinical Lung Cancer. 19:e783-e799

    مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cost-Benefit Analysis, medicine.medical_treatment, Adenocarcinoma, Medicare, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Salvage Therapy, Chemotherapy, business.industry, Retrospective cohort study, Prognosis, medicine.disease, United States, Gemcitabine, Carboplatin, Survival Rate, 030104 developmental biology, Pemetrexed, chemistry, Docetaxel, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Carcinoma, Large Cell, Female, business, Follow-Up Studies, SEER Program, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761d8d6bf8abef28d83a587fc3e50bfdTest
    https://doi.org/10.1016/j.cllc.2018.05.016Test


    أضف إلى المفضلة
  2. 2
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study

    المؤلفون: Jinghua He, David P. Carbone, Yichen Zhong, Haojie Li, Ashwini Arunachalam, Gregory M. Lubiniecki, Ramon E. Camacho, Marisa A. Bittoni

    المصدر: Clinical lung cancer. 19(5)

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Cost-Benefit Analysis, Medicare, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, Retrospective cohort study, medicine.disease, Prognosis, Carboplatin, Gemcitabine, United States, Survival Rate, Pemetrexed, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Female, business, medicine.drug, Follow-Up Studies, SEER Program

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050539ccc4c397e8b5db89243c7043cbTest
    https://pubmed.ncbi.nlm.nih.gov/29885945Test


    أضف إلى المفضلة
  3. 3
    Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis

    المؤلفون: Robert E. Merritt, Anna O. D'Souza, Rebecca J. Nagy, Tasneem Lokhandwala, Robert Dann, Marisa A. Bittoni, David P. Carbone, Richard B. Lanman, Meridith Johnson

    المصدر: Clinical lung cancer. 18(1)

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Computed tomography, Medicare, 03 medical and health sciences, Insurance Claim Review, 0302 clinical medicine, Biopsy, medicine, Humans, In patient, Adverse effect, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, medicine.diagnostic_test, business.industry, Retrospective cohort study, Mean age, Health Care Costs, medicine.disease, Prognosis, United States, 030228 respiratory system, Oncology, 030220 oncology & carcinogenesis, Diagnostic assessment, Female, Radiology, business, Tomography, X-Ray Computed, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a271835ba0200b2e41e521f6bebb45fTest
    https://pubmed.ncbi.nlm.nih.gov/27530054Test


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.

    المؤلفون: Arunachalam, Ashwini, Haojie Li, Bittoni, Marisa A., Camacho, Ramon, Xiting Cao, Yichen Zhong, Lubiniecki, Gregory M., Carbone, David P., Li, Haojie, Cao, Xiting, Zhong, Yichen

    المصدر: Clinical Lung Cancer; Sep2018, Vol. 19 Issue 5, pe783-e799, 17p


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.

    المؤلفون: Bittoni, Marisa A., Arunachalam, Ashwini, Haojie Li, Camacho, Ramon, Jinghua He, Yichen Zhong, Lubiniecki, Gregory M., Carbone, David P., Li, Haojie, He, Jinghua, Zhong, Yichen

    المصدر: Clinical Lung Cancer; Sep2018, Vol. 19 Issue 5, pe629-e645, 17p


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.

    المؤلفون: Lokhandwala, Tasneem, Bittoni, Marisa A, Dann, Robert A, D'Souza, Anna O, Johnson, Meridith, Nagy, Rebecca J, Lanman, Richard B, Merritt, Robert E, Carbone, David P

    المصدر: Clinical Lung Cancer; Jan2017, Vol. 18 Issue 1, pe27-e34, 8p


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث